脂質膜を通るパッシブマクロモレキュラトランスロケーション機構
Ekaterina Kostyurina1, Jürgen Allgaier1, Margarita Kruteva1
1Jülich Centre for Neutron Science (JCNS-1) and Institute for Biological Information Processing (IBI-8), Forschungszentrum Jülich GmbH, 52428 Jülich, Germany.
Journal of the American Chemical Society
|August 11, 2022
まとめ
研究者は細胞膜の転移と薬剤の投与を 強化するためのマクロモレキュルの設計に関するガイドラインを開発した. 最適な条件により,様々な化学構造が効率的な受動的転移を実現することができ,これは標的治療に不可欠です.
科学分野:
- バイオ物理学
- 材料科学
- 薬物の配達
背景:
- マクロモレキュルの細胞膜転移は,生物学的プロセスと薬物投与に不可欠です.
- タンパク質は 膜を通過するのに 形状の変化を使いますが 合成マクロモレキュルは 構造的調整が必要です
- ガイドラインの欠如は,効果的なマクロ分子薬媒体の開発を妨げています.
研究 の 目的:
- マクロ分子構造と環境要因が膜分割と転位にどのように影響するか調査する.
- 合成マクロモレキュルの設計に関するガイドラインを確立し,効率的な膜横断薬剤投与を実現する.
- 脂質二層にわたる受動的なマクロ分子転移の基本的メカニズムを理解する.
主な方法:
- 交替するアンフィフィリックマクロモレキュルの体系的な調査.
- パルスフィールドグラデントNMRとコンフォカル光顕微鏡を用いた.
- 量化された膜吸附/脱吸収率と分割係数
主要な成果:
- マクロ分子転移は2段階のプロセスである:迅速な吸附/挿入に続く緩やかな脱吸収.
- 膜挿入は重要で,分子量,濃度,および温度に依存します.
- 特定の化学構造とは無関係な多様なモノマー配列で最適化トランスロケーション条件を達成できます.
結論:
- パッシブ・トランスロケーションは数分から数時間以内に発生し,有効な薬物投与の窓を提供します.
- 開発されたガイドラインは,改善された膜転移のためにマクロモレキュルの構造を調整することを可能にします.
- バイオコンパティブルで生物分解性のある共ポリマーは,水害性のペイロードを効果的に輸送し,マクロ分子キャリア設計を進める.
関連する概念動画
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
748
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
748
Drug Absorption Mechanism: Passive Membrane Transport
4.4K
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
4.4K
Passive Diffusion: Overview and Kinetics
667
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
667
Cotranslational Protein Translocation
7.5K
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
7.5K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.2K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.2K
Protein Diffusion in the Membrane
4.5K
Proteins show rotational as well as lateral diffusion across the membrane. The lateral diffusion of proteins was confirmed through the cell fusion experiment where mouse and human cells were fused, resulting in hybrid cells. When the human and mouse cells fused, the specific membrane proteins on human and mouse cells were marked with the red and green-fluorescent markers, respectively. Initially, the red and green fluorescence was located on the respective hemisphere of the cell. As time...
4.5K


